JP Morgan Chase’s Agios Pharmaceuticals AGIO Stock Holding History
Bought
Maintained
Sold
Other funds holding AGIO
JP Morgan Chase's AGIO Position: Q3 2026 in Review
JP Morgan Chase reduced its Agios Pharmaceuticals (AGIO) stake by 82% in Q3 2026, selling an estimated $10.3M and leaving 64,123 shares worth $2.24M. The position accounts for ﹤0.01% of the portfolio, ranked #4173.
JP Morgan Chase first reported a position in AGIO in Q3 2013 and has held it in 53 quarters since. The position peaked at $284M in Q2 2021. 243 funds tracked by Wall St. Rank hold AGIO as of Q3 2026.
- JP Morgan Chase held 64,123 shares of Agios Pharmaceuticals worth $2.24M as of Q3 2026.
- JP Morgan Chase sold 295,633 Agios Pharmaceuticals shares in Q3 2026, an estimated $10.3M.
- Agios Pharmaceuticals made up ﹤0.01% of JP Morgan Chase's portfolio in Q3 2026, its #4173 holding.
- JP Morgan Chase first reported a position in Agios Pharmaceuticals in Q3 2013 and has held it in 53 quarters since.
- JP Morgan Chase's Agios Pharmaceuticals position peaked at $284M in Q2 2021.
- 243 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2026.
Based on JP Morgan Chase's 13F filing for Q3 2026, filed 12 Nov 2026.